*Department of Pathology, Charles University, Faculty of Medicine in Plzen
†Bioptic Laboratory Ltd
¶Molecular and Genetic Laboratory, Bioptic Laboratory Ltd, Plzen
‡The Fingerland Department of Pathology, Charles University, Faculty of Medicine and University Hospital Hradec Kralove, Hradec Králové
§§Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine in Prague, Prague, Charles University and Motol University Hospital, Prague, Czech Republic
§Department of Histopathology, Division of Clinical Medicine, University of Surrey, Royal Surrey County Hospital, Guildford, Surrey, UK
∥Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Comprehensive Cancer Center (CCC) Erlangen-EMN, Erlangen, Germany
#Department of Pathology, CHU Gui de Chauliac, Montpellier, France
**Department of Pathology, National University Health System, Singapore, Singapore
††Department of Pathology, Research Institute GROW, Maastricht University Medical Center, Maastricht, The Netherlands
‡‡Department of Anatomic Histopathology and Cytogenetics, Department of Laboratory Medicine, Niguarda Cancer Center, Milan, Italy
∥∥Medical Laboratory CSD, Kyiv, Ukraine
¶¶Institute of Biomedicine, Pathology, University of Turku, and Turku University Hospital, Turku, Finland
Conflicts of Interest and Source of Funding: Supported in part by study grant SVV 22639 from the Ministry of Education, Czech Republic and the Finnish Cancer Society, Helsinki. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Correspondence: Alena Skálová, MD, PhD, Sikl’s Department of Pathology, Faculty of Medicine in Pilsen, Charles University, E. Benese 13, 305 99 Pilsen, Czech Republic (e-mail: [email protected]).